Francesc Català Moll
He holds a degree in Biotechnology from the University of Girona (2015). He then did a Master's degree in Genetics and Genomics at the University of Barcelona (2016). During the last year of the degree, he joined the group of Epigenetics and Immune Diseases at IDIBELL, under the supervision of Dr. Esteban Ballestar. It was there that he also carried out his PhD thesis in biomedicine at the University of Barcelona (which ended in June 2020).
During his PhD he focused his research on the study of molecular mechanisms associated with the active demethylation of DNA and its targeting at the genomic level through the use of some myeloid differentiation models. During his pre-doctoral training, he also spent an international stay at the German Cancer Research Center (DKFZ), where he was trained in the generation and analysis of T-WGBS and ATAC-seq.
He is now part of the Microbial Genomics group, as DataSteward, to contribute to the development of bioinformatic tools for the study of the microbiome and its relationship with HIV infection.
JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in Sepsis.
Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.
Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses.
Vitamin D receptor, STAT3, and TET2 cooperate to establish tolerogenesis.
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.